Forty-four patients -LSB- @ females , age @ years , disease duration @ months , simplified disease activity index ( SDAI ) @ , CRP @ mg/l , ESR @ mm/h , MMP-@ @ pg/ml , RF @ IU/ml , neutrophil count @ per l , lymphocyte count @ per l -RSB- were treated with tofacitinib .